Discounted Cash Flow (DCF) Analysis Levered

Bruush Oral Care Inc. (BRSH)

$0.054

-0.00 (-4.93%)
All numbers are in Millions, Currency in USD
Stock DCF: -8,826.12 | 0.054 | overvalue

Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.210.902.622.637.2519.9454.90151.10415.90
Revenue (%)
Operating Cash Flow -1.46-4.05-0.89-12.59-30.18-83.06-228.62-629.28-1,732.08
Operating Cash Flow (%)
Capital Expenditure --0-0.01-0-0.02-0.05-0.14-0.38-1.04
Capital Expenditure (%)
Free Cash Flow -1.46-4.06-0.90-12.59-30.19-83.11-228.76-629.65-1,733.12

Weighted Average Cost Of Capital

Share price $ 0.054
Beta 0.000
Diluted Shares Outstanding 7.34
Cost of Debt
Tax Rate 63.74
After-tax Cost of Debt 1.81%
Risk-Free Rate
Market Risk Premium
Cost of Equity 4.285
Total Debt -
Total Equity 0.40
Total Capital 0.40
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.210.902.622.637.2519.9454.90151.10415.90
Operating Cash Flow -1.46-4.05-0.89-12.59-30.18-83.06-228.62-629.28-1,732.08
Capital Expenditure --0-0.01-0-0.02-0.05-0.14-0.38-1.04
Free Cash Flow -1.46-4.06-0.90-12.59-30.19-83.11-228.76-629.65-1,733.12
WACC
PV LFCF -30.19-79.69-210.32-555.10-1,465.07
SUM PV LFCF -2,244.11

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 4.29
Free cash flow (t + 1) -1,767.78
Terminal Value -77,195.73
Present Value of Terminal Value -62,571.98

Intrinsic Value

Enterprise Value -64,816.09
Net Debt -0.07
Equity Value -64,816.02
Shares Outstanding 7.34
Equity Value Per Share -8,826.12